Duty to Warn: Antidepressants in Children and Adolescents

For nearly 17 years, since the FDA black box warning about suicidality with antidepressants, our community has been quoting data that downplays this concern. We were wrong. We were deceived. Antidepressants can be lifesaving, but there really is a duty to warn. In this episode, Doctors Martha Ignaszewski and Glen Spielmans talk with us about what went on and how to talk about it with our families.

Listen to my Carlat Psychiatry podcast

https://www.thecarlatreport.com/podcast/duty-to-warn-antidepressants-in-children-and-adolescents/

Guests: 

Published On: 3/1/2021

Duration: 24 minutes, 36 seconds

Related Articles:

References:
Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

How Effective is Atomoxetine in Children and Adolescents?

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. Does it work? Listen and find out!

Discussing Stimulant Treatment with Parents

ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?

Treating Children of Divorce

Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?